Pablo Peña-Tapia
Pablo Peña-Tapia has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Peter Vajkoczy
6 shared publications- Gerrit Alexander Schubert
Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland
5 shared publications Peter Schmiedek
University Hospital Mannheim, University of Heidelberg
5 shared publications- Efrén Vázquez-Silva
Grupo de Investigación en Nuevos Materiales y Procesos de Transformación (GIMAT), Department of Mechanical Engineering, Universidad Politécnica Salesiana, Sede Cuenca EC010102, Ecuador
3 shared publications - Marcus Czabanka
Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany
3 shared publications P. Schmiedek
Department of Neurosurgery, Klinikum Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
3 shared publications
Latest Publications
- Open Access
- 24 December 2025
- Published by Universidad de Cuenca in Revista de la Facultad de Ciencias Médicas de la Universidad de Cuenca
- Vol. 43 (3)
Implementación del Comité de Neuro-Oncología en SOLCA-Cuenca: experiencia de dos años
Introducción: las reuniones multidisciplinarias constituyen el estándar de oro para el manejo de pacientes con cáncer y son un requisito para la certificación de centros oncológicos. Sin embargo, existen pocos estudios sobre la implementación de comités de neuro-oncología en América Latina. Objetivo: describir el proceso de implementación y los primeros 24 meses de funcionamiento del Comité de Neuro-Oncología (CNO) del Hospital SOLCA de Cuenca, Ecuador. Metodología: estudio descriptivo, retrospectivo de casos discutidos en el CNO entre marzo 2019-julio 2021. Se registraron variables demográficas, clínicas, del comité y de seguimiento mediante revisión de historias clínicas electrónicas y análisis estadístico descriptivo. Resultados: se discutieron 126 casos correspondientes a 87 pacientes en 59 sesiones. La edad media fue 43 años, 54% mujeres y 69% procedentes de Azuay. El 83,9% tuvo confirmación histopatológica. Predominaron tumores gliales primarios (41,4%), tumores benignos de base craneal (34,5%) y metástasis (6,9%). El CNO recomendó terapia antitumoral en 46,03% de los casos, procedimientos diagnósticos en 20,63% y vigilancia en 33,33%. La adherencia total fue 67,5% y parcial, 4,8%. Conclusiones: el CNO de SOLCA-Cuenca se consolidó como órgano clave para el manejo de tumores del sistema nervioso con alta adherencia (72,3%). La experiencia demuestra la viabilidad de implementar comités multidisciplinarios en la región y sugiere su difusión para fortalecer la neuro-oncología en Latinoamérica.
- 24 December 2025
- Published by Universidad de Cuenca in Revista de la Facultad de Ciencias Médicas de la Universidad de Cuenca
- Vol. 43 (3)
Open AccessImplementación del Comité de Neuro-Oncología en SOLCA-Cuenca: experiencia de dos años
Introducción: las reuniones multidisciplinarias constituyen el estándar de oro para el manejo de pacientes con cáncer y son un requisito para la certificación de centros oncológicos. Sin embargo, existen pocos estudios sobre la implementación de comités de neuro-oncología en América Latina. Objetivo: describir el proceso de implementación y los primeros 24 meses de funcionamiento del Comité de Neuro-Oncología (CNO) del Hospital SOLCA de Cuenca, Ecuador. Metodología: estudio descriptivo, retrospectivo de casos discutidos en el CNO entre marzo 2019-julio 2021. Se registraron variables demográficas, clínicas, del comité y de seguimiento mediante revisión de historias clínicas electrónicas y análisis estadístico descriptivo. Resultados: se discutieron 126 casos correspondientes a 87 pacientes en 59 sesiones. La edad media fue 43 años, 54% mujeres y 69% procedentes de Azuay. El 83,9% tuvo confirmación histopatológica. Predominaron tumores gliales primarios (41,4%), tumores benignos de base craneal (34,5%) y metástasis (6,9%). El CNO recomendó terapia antitumoral en 46,03% de los casos, procedimientos diagnósticos en 20,63% y vigilancia en 33,33%. La adherencia total fue 67,5% y parcial, 4,8%. Conclusiones: el CNO de SOLCA-Cuenca se consolidó como órgano clave para el manejo de tumores del sistema nervioso con alta adherencia (72,3%). La experiencia demuestra la viabilidad de implementar comités multidisciplinarios en la región y sugiere su difusión para fortalecer la neuro-oncología en Latinoamérica.
- Open Access
Finite Element Analysis of Patient-Specific 3D-Printed Cranial Implant Manufactured with PMMA and PEEK: A Mechanical Comparative Study
This article reports on a patient who required a cranial protection system. Using additive manufacturing techniques and surgical planning with the help of bio-models, a patient-specific bone implant solution was proposed that allows aesthetic restoration of the affected area and provides an adequate level of protection. In addition, through a comparative analysis with finite elements, the mechanical response to external actions of the medical device, printed with two materials: polymethylmethacrylate (PMMA) and polyether-ether-ketone (PEEK), is simulated. The tested materials have recognized biocompatibility properties, but their costs on the market differ significantly. The results obtained demonstrate the similarities in the responses of both materials. It offers the possibility that low-income people can access these devices, guaranteeing adequate biomechanical safety, considering that PMMA is a much cheaper material than PEEK.
Open AccessFinite Element Analysis of Patient-Specific 3D-Printed Cranial Implant Manufactured with PMMA and PEEK: A Mechanical Comparative Study
This article reports on a patient who required a cranial protection system. Using additive manufacturing techniques and surgical planning with the help of bio-models, a patient-specific bone implant solution was proposed that allows aesthetic restoration of the affected area and provides an adequate level of protection. In addition, through a comparative analysis with finite elements, the mechanical response to external actions of the medical device, printed with two materials: polymethylmethacrylate (PMMA) and polyether-ether-ketone (PEEK), is simulated. The tested materials have recognized biocompatibility properties, but their costs on the market differ significantly. The results obtained demonstrate the similarities in the responses of both materials. It offers the possibility that low-income people can access these devices, guaranteeing adequate biomechanical safety, considering that PMMA is a much cheaper material than PEEK.
- 28 July 2023
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 146, 106046
Finite element analysis of a customized implant in PMMA coupled with the cranial bone
- 28 July 2023
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 146, 106046
Finite element analysis of a customized implant in PMMA coupled with the cranial bone
- 30 November 2019
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 11 (3) , 229-234
Serie de Casos Clínicos: Displasia Osteofibrosa Craneofacial. Resolución Quirúrgica
INTRODUCCIÓN: La Displasia Fibrosa Ósea Craneofacial es una lesión ósea benigna en la que se da una sustitución de tejido óseo normal por tejido fibro-óseo. Desarrollada a partir de una mutación genética. Subordinada en variantes: monostósica y polistósica. Escasos casos son reportados sobre malignización de la patología. El Diagnóstico se realiza con la sospecha clínica y se confirma mediante exámenes de imagen y anatomopatológicos. CASO CLÍNICO: El presente trabajo presenta una serie de tres casos diagnosticados de Displasia Osteofibrosa Craneofacial en el Hospital José Carrasco Arteaga y Hospital del Río, Cuenca-Ecuador, en los que por el cuadro clínico de los pacientes se decidió tratamiento quirúrgico. EVOLUCIÓN: En todos los casos, la evolución fue favorable. Se logró resultados positivos, reducción de síntomas y mejoría estética general en todos los casos. CONCLUSIÓN: Se obtienen mejores resultados con los tratamientos quirúrgicos actuales (remodelado más congelamiento óseo), entre ellos: buenos resultados estéticos, mejor calidad de vida, menor riesgo de infecciones. En el presente trabajo los tres participantes sometidos a resolución quirúrgica señalaron que el tratamiento reflejó positivamente en el ámbito funcional, estético y emocional. ABSTRACT BACKGROUND: Craniofacial Bone Fibrous Dysplasia is a benign bone lesion where normal bone tissue is replaced with fibrous tissue. Developed from a genetic mutation. Subordinated in variants: monostotic and polyistotic. Few cases are reported on malignancy of the pathology. The diagnosis is determined with clinical suspicion and confirmed by imaging and pathology tests. CASE REPORT: In this paper, we present a series of three cases diagnosed with Craniofacial Fibrous Dysplasia at José Carrasco Arteaga Hospital and Hospital del Río, Cuenca-Ecuador. All of patients were treated with surgery, because of the clinical features. EVOLUTION: In all the cases, the patient evolution was favorable. Reduction of symptoms and general aesthetic improvement were achieved in all cases. CONCLUSION: Better results are obtained with the current surgical treatments (bone remodeling plus bone freezing), among them: good aesthetic results, better quality of life, lower risk of infections. In the present paper, the three patients treated with the surgical procedure indicated that the treatment reflected positively in the functional, aesthetic and emotional aspects.
- 30 November 2019
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 11 (3) , 229-234
Serie de Casos Clínicos: Displasia Osteofibrosa Craneofacial. Resolución Quirúrgica
INTRODUCCIÓN: La Displasia Fibrosa Ósea Craneofacial es una lesión ósea benigna en la que se da una sustitución de tejido óseo normal por tejido fibro-óseo. Desarrollada a partir de una mutación genética. Subordinada en variantes: monostósica y polistósica. Escasos casos son reportados sobre malignización de la patología. El Diagnóstico se realiza con la sospecha clínica y se confirma mediante exámenes de imagen y anatomopatológicos. CASO CLÍNICO: El presente trabajo presenta una serie de tres casos diagnosticados de Displasia Osteofibrosa Craneofacial en el Hospital José Carrasco Arteaga y Hospital del Río, Cuenca-Ecuador, en los que por el cuadro clínico de los pacientes se decidió tratamiento quirúrgico. EVOLUCIÓN: En todos los casos, la evolución fue favorable. Se logró resultados positivos, reducción de síntomas y mejoría estética general en todos los casos. CONCLUSIÓN: Se obtienen mejores resultados con los tratamientos quirúrgicos actuales (remodelado más congelamiento óseo), entre ellos: buenos resultados estéticos, mejor calidad de vida, menor riesgo de infecciones. En el presente trabajo los tres participantes sometidos a resolución quirúrgica señalaron que el tratamiento reflejó positivamente en el ámbito funcional, estético y emocional. ABSTRACT BACKGROUND: Craniofacial Bone Fibrous Dysplasia is a benign bone lesion where normal bone tissue is replaced with fibrous tissue. Developed from a genetic mutation. Subordinated in variants: monostotic and polyistotic. Few cases are reported on malignancy of the pathology. The diagnosis is determined with clinical suspicion and confirmed by imaging and pathology tests. CASE REPORT: In this paper, we present a series of three cases diagnosed with Craniofacial Fibrous Dysplasia at José Carrasco Arteaga Hospital and Hospital del Río, Cuenca-Ecuador. All of patients were treated with surgery, because of the clinical features. EVOLUTION: In all the cases, the patient evolution was favorable. Reduction of symptoms and general aesthetic improvement were achieved in all cases. CONCLUSION: Better results are obtained with the current surgical treatments (bone remodeling plus bone freezing), among them: good aesthetic results, better quality of life, lower risk of infections. In the present paper, the three patients treated with the surgical procedure indicated that the treatment reflected positively in the functional, aesthetic and emotional aspects.
- Open Access
- 30 November 2017
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 9 (3) , 285-290
Caso Clínico: Uso de Biomodelos Tridimensionales para la Planificación Preoperatoria de Tumores Craneales Fronto - orbitarios
Caso Clínico: Uso de Biomodelos Tridimensionales para la planificación preoperatoria de Tumores Craneales fronto-orbitarios
- 30 November 2017
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 9 (3) , 285-290
Open AccessCaso Clínico: Uso de Biomodelos Tridimensionales para la Planificación Preoperatoria de Tumores Craneales Fronto - orbitarios
Caso Clínico: Uso de Biomodelos Tridimensionales para la planificación preoperatoria de Tumores Craneales fronto-orbitarios
- Open Access
- 1 March 2017
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 4 (2) , e324
Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis
Objective: To prospectively evaluate the validity of a PCR assay in CSF for the diagnosis of neurocysticercosis (NC). Methods: We conducted a multicenter, prospective case-control study, recruiting participants from 5 hospitals in Cuenca, Ecuador, from January 2015 to February 2016. Cases fulfilled validated diagnostic criteria for NC. For each case, a neurosurgical patient who did not fulfill the diagnostic criteria for NC was selected as a control. CT and MRI, as well as a CSF sample, were collected from both cases and controls. The diagnostic criteria to identify cases were used as a reference standard. Results: Overall, 36 case and 36 control participants were enrolled. PCR had a sensitivity of 72.2% (95% confidence interval [CI] 54.8%–85.8%) and a specificity of 100.0% (95% CI 90.3%–100.0%). For parenchymal NC, PCR had a sensitivity of 42.9% (95% CI 17.7%–71.1%), and for extraparenchymal NC, PCR had a sensitivity of 90.9% (95% CI 70.8%–98.9%). Conclusions: This study demonstrated the usefulness of this PCR assay in CSF for the diagnosis of NC. PCR may be particularly helpful for diagnosing extraparenchymal NC when neuroimaging techniques have failed. Classification of evidence: This study provides Class III evidence that CSF PCR can accurately identify patients with extraparenchymal NC.
- 1 March 2017
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 4 (2) , e324
Open AccessValidity of a PCR assay in CSF for the diagnosis of neurocysticercosis
Objective: To prospectively evaluate the validity of a PCR assay in CSF for the diagnosis of neurocysticercosis (NC). Methods: We conducted a multicenter, prospective case-control study, recruiting participants from 5 hospitals in Cuenca, Ecuador, from January 2015 to February 2016. Cases fulfilled validated diagnostic criteria for NC. For each case, a neurosurgical patient who did not fulfill the diagnostic criteria for NC was selected as a control. CT and MRI, as well as a CSF sample, were collected from both cases and controls. The diagnostic criteria to identify cases were used as a reference standard. Results: Overall, 36 case and 36 control participants were enrolled. PCR had a sensitivity of 72.2% (95% confidence interval [CI] 54.8%–85.8%) and a specificity of 100.0% (95% CI 90.3%–100.0%). For parenchymal NC, PCR had a sensitivity of 42.9% (95% CI 17.7%–71.1%), and for extraparenchymal NC, PCR had a sensitivity of 90.9% (95% CI 70.8%–98.9%). Conclusions: This study demonstrated the usefulness of this PCR assay in CSF for the diagnosis of NC. PCR may be particularly helpful for diagnosing extraparenchymal NC when neuroimaging techniques have failed. Classification of evidence: This study provides Class III evidence that CSF PCR can accurately identify patients with extraparenchymal NC.
- 30 August 2016
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 158 (10) , 1895-1900
Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery
Background Moyamoya disease (MMD) may be graded based on DSA, the presence of ischemia in MRI and cerebrovascular reserve capacity allowing the prediction of ischemic symptoms in patients. Cerebral ischemia represents a severe complication in revascularization surgery. Focusing on different clinical features of hemodynamic impairment, MMD grading may allow prediction of ischemic complications. It was the aim to analyze whether MMD grading stratifies for ischemic complications in revascularization surgery for MMD. Method In 37 MMD patients a bilateral, standardized, one-staged revascularization approach consisting of STA-MCA bypass/encephalomyosynangiosis (EMS) and single EMS on the contralateral hemisphere was performed. Clinical data including DSA, MRI and rCBF (Xenon-CT) studies were assessed and used for grading MMD. All patients were observed on the ICU for at least 24 h and received CT imaging on the first postoperative day and in case of neurological deterioration. Ischemic complications were analyzed until the day of discharge and at 6-month follow-up. Results Grading of MMD revealed 11 hemispheres (15 %) as grade I, 33 hemispheres (44 %) as grade II and 30 hemispheres (41 %) as grade III. Eight ischemic complications were observed (11 %). MMD grading demonstrated a significant correlation with ischemic complications: 0 complications in grade I, 3 in grade II (9 %) and 5 in grade III hemispheres (16 %; p < 0.05, Fisher’s exact test). Conclusions The proposed grading system allows to stratify for ischemic complications in MMD patients that receive bilateral, one-staged revascularization surgery. Future studies will have to investigate its use for predicting ischemic complications in other revascularization strategies for MMD.
- 30 August 2016
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 158 (10) , 1895-1900
Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery
Background Moyamoya disease (MMD) may be graded based on DSA, the presence of ischemia in MRI and cerebrovascular reserve capacity allowing the prediction of ischemic symptoms in patients. Cerebral ischemia represents a severe complication in revascularization surgery. Focusing on different clinical features of hemodynamic impairment, MMD grading may allow prediction of ischemic complications. It was the aim to analyze whether MMD grading stratifies for ischemic complications in revascularization surgery for MMD. Method In 37 MMD patients a bilateral, standardized, one-staged revascularization approach consisting of STA-MCA bypass/encephalomyosynangiosis (EMS) and single EMS on the contralateral hemisphere was performed. Clinical data including DSA, MRI and rCBF (Xenon-CT) studies were assessed and used for grading MMD. All patients were observed on the ICU for at least 24 h and received CT imaging on the first postoperative day and in case of neurological deterioration. Ischemic complications were analyzed until the day of discharge and at 6-month follow-up. Results Grading of MMD revealed 11 hemispheres (15 %) as grade I, 33 hemispheres (44 %) as grade II and 30 hemispheres (41 %) as grade III. Eight ischemic complications were observed (11 %). MMD grading demonstrated a significant correlation with ischemic complications: 0 complications in grade I, 3 in grade II (9 %) and 5 in grade III hemispheres (16 %; p < 0.05, Fisher’s exact test). Conclusions The proposed grading system allows to stratify for ischemic complications in MMD patients that receive bilateral, one-staged revascularization surgery. Future studies will have to investigate its use for predicting ischemic complications in other revascularization strategies for MMD.
- 25 September 2014
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 156 (11) , 2051-2058
Collateralization and ischemia in hemodynamic cerebrovascular insufficiency
Moyamoya disease and atherosclerotic cerebrovascular occlusive disease lead to hemodynamic impairment of cerebral blood flow. One major differentiation between both disease entities lies in the collateralization pathways. The clinical implications of the collateralization pathways for the development of hemodynamic ischemia remain unknown. The aim was to characterize collateralization and ischemia patterns in patients with chronic hemodynamic compromise.
- 25 September 2014
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 156 (11) , 2051-2058
Collateralization and ischemia in hemodynamic cerebrovascular insufficiency
Moyamoya disease and atherosclerotic cerebrovascular occlusive disease lead to hemodynamic impairment of cerebral blood flow. One major differentiation between both disease entities lies in the collateralization pathways. The clinical implications of the collateralization pathways for the development of hemodynamic ischemia remain unknown. The aim was to characterize collateralization and ischemia patterns in patients with chronic hemodynamic compromise.